Sophie Postel-Vinay, is currently Physician Scientist at the Drug Development Department and U981 INSERM research unit of Gustave Roussy Cancer Campus, where she leads an independent research group as of January 2018 thanks to the ATIP-Avenir INSERM/CNRS grant.
She received her medical degree from the Université Paris XI in 2010, and joined the faculty in November 2013 after completion of her PhD performed at the Institute of Cancer Research (London), which focused on DNA repair and synthetic lethality. She completed her residency training in Paris, and spent 18 months at the Royal Marsden Hospital of London at the Drug Development Unit. Dr Postel-Vinay is member of ESMO, AACR and ASCO.
Dr Postel-Vinay has a Physician Scientist position at Gustave Roussy since 2016, which allows her to have a fundamental research activity within the INSERM Unit 981 in parallel of her clinical drug development activity (which is exclusively drug development and early phase trials). She obtained in 2017 the ATIP-Avenir “Young Group Leader” grant from INSERM/CNRS, which allowed her to develop her own independent group. She was granted the “Prix Irène Joliot-Curie” from the French Academy of Sciences in 2019 for her work on DNA repair. Her current research activity focuses on chromatin remodeling and its interplay with DNA repair and immune modulation in solid tumors. Her research interests include DNA repair, chromatin remodeling, synthetic lethality, lung, sarcoma, predictive biomarkers and drug development.